{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:46:39Z","timestamp":1791452799159,"version":"4.3.3"},"update-to":[{"DOI":"10.1002\/14651858.cd003511.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000}}],"reference-count":91,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003511.pub5","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T03:25:00Z","timestamp":1574220300000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology"],"prefix":"10.1002","author":[{"given":"David M","family":"Haas","sequence":"first","affiliation":[{"name":"Indiana University School of Medicine; Department of Obstetrics and Gynecology; 1001 West 10th Street, F-5 Indianapolis Indiana USA 46202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor J","family":"Hathaway","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine; Department of Obstetrics and Gynecology; 1001 West 10th Street, F-5 Indianapolis Indiana USA 46202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S","family":"Ramsey","sequence":"additional","affiliation":[{"name":"Uniformed Services University of Health Sciences; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology; Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,11,20]]},"reference":[{"key":"10.1002\/14651858.CD003511.pub5-BIB0001|cit1","unstructured":"CTRI\/2016\/09\/007278 Role of inflammatory markers in recurrent pregnancy loss and effect of oral micronized therapy on these cases ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=14740"},{"issue":"22","key":"10.1002\/14651858.CD003511.pub5-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1056\/NEJMoa1504927","article-title":"A randomized trial of progesterone in women with recurrent miscarriages","volume":"373","author":"Coomarasamy","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"41","key":"10.1002\/14651858.CD003511.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3310\/hta20410","article-title":"PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation","volume":"20","author":"Coomarasamy","year":"2016","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0004|cit4","unstructured":"ISRCTN92644181 First trimester progesterone therapy in women with a history of unexplained recurrent miscarriages: a randomised double-blind placebo-controlled multi-centre trial (The PROMISE [PROgesterone in recurrent MIScarriagE] Trial) controlled-trials.com\/ISRCTN92644181"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003511.pub5-BIB0005|cit5","first-page":"136","article-title":"Randomized clinical trial comparing the efficacy of dydrogesterone and human chorionic gonadotropin","volume":"5","author":"Zibdeh","year":"2002","journal-title":"Climacteric"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD003511.pub5-BIB0006|cit6","first-page":"S77","article-title":"Randomized study comparing the efficacy of reducing spontaneous abortion following treatment with progesterone and human chorionic gonadotropin (hCG)","volume":"70","author":"Zibdeh","year":"1998","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD003511.pub5-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jsbmb.2005.08.007","article-title":"Dydrogesterone in the reduction of recurrent spontaneous abortion","volume":"97","author":"El-Zibdeh","year":"2005","journal-title":"Journal of Steroid Biochemistry & Molecular Biology"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0008|cit8","unstructured":"CTRI\/2013\/02\/003406 Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent spontaneous miscarriage ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=5847"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003511.pub5-BIB0009|cit9","first-page":"P089","article-title":"Assessment of endometrial vascularity following dydrogesterone and micronized progesterone administration in idiopathic recurrent miscarriage-a preliminary study","volume":"27","author":"Chakravarty","year":"2012","journal-title":"Human Reproduction"},{"issue":"7","key":"10.1002\/14651858.CD003511.pub5-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/jog.12456","article-title":"Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study","volume":"40","author":"Ghosh","year":"2014","journal-title":"Journal of Obstetrics & Gynaecology Research"},{"issue":"7","key":"10.1002\/14651858.CD003511.pub5-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/jama.1964.03060330031008","article-title":"Double-blind trial of a progestin in habitual abortion","volume":"188","author":"Goldzieher","year":"1964","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/j.1471-0528.1965.tb01533.x","article-title":"Hormones in recurrent abortion","volume":"72","author":"Klopper","year":"1965","journal-title":"Journal of Obstetrics and Gynaecology of the British Commonwealth"},{"issue":"5","key":"10.1002\/14651858.CD003511.pub5-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.fertnstert.2014.07.1251","article-title":"Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trial","volume":"102","author":"Kumar","year":"2014","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0014|cit14","first-page":"30","article-title":"Habitual abortion. A controlled clinical study of progestational therapy","volume":"72","author":"Vine","year":"1964","journal-title":"Western Journal of Surgery"},{"issue":"3","key":"10.1002\/14651858.CD003511.pub5-BIB0015|cit15","first-page":"394","article-title":"Cervical mucus, vaginal cytology and steroid excretion in recurrent abortion","volume":"40","author":"MacDonald","year":"1972","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1471-0528.1988.tb12797.x","article-title":"Endocrine effects of 17 alpha-hydroxyprogesterone caproate during early pregnancy: a double-blind clinical trial","volume":"95","author":"Reijnders","year":"1988","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/bmj.1.5326.292","article-title":"Double-blind study of effect of 17-hydroxyprogesterone caproate on abortion rate","volume":"1","author":"Shearman","year":"1963","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0018|cit18","first-page":"767","article-title":"Hormonal treatment of habitual abortion","volume-title":"In: Progress In Infertility. Kistner RW (ed)","author":"Shearman","year":"1968"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/bmj.1.4819.1073","article-title":"Progesterone implantation in habitual abortion","volume":"1","author":"Swyer","year":"1953","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0020|cit20","first-page":"353","article-title":"Is hormonal therapy still justified in imminent abortion?","volume":"184","author":"Berle","year":"1980","journal-title":"Zeitschrift fur Geburtshilfe und Perinatologie"},{"issue":"8","key":"10.1002\/14651858.CD003511.pub5-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0002-9378(16)35945-2","article-title":"Effect of medroxyprogesterone acetate upon the duration and characteristics of human gestation labour","volume":"83","author":"Brenner","year":"1962","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD003511.pub5-BIB0022|cit22","first-page":"45","article-title":"Decreased abortion in HMG-induced pregnancies","volume":"30","author":"Check","year":"1985","journal-title":"International Journal of Fertility"},{"issue":"3","key":"10.1002\/14651858.CD003511.pub5-BIB0023|cit23","first-page":"192","article-title":"Progesterone therapy to decrease first-trimester spontaneous abortions in previous aborters","volume":"32","author":"Check","year":"1987","journal-title":"International Journal of Fertility"},{"issue":"2","key":"10.1002\/14651858.CD003511.pub5-BIB0024|cit24","first-page":"135","article-title":"The efficacy of progesterone in achieving successful pregnancy: prophylactic use during luteal phase in anovulatory women","volume":"32","author":"Check","year":"1987","journal-title":"International Journal of Fertility"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000292421","article-title":"A randomized study comparing the efficacy of reducing the spontaneous abortion rate following lymphocyte immunotherapy and progesterone treatment vs progesterone alone in primary habitual aborters","volume":"39","author":"Check","year":"1995","journal-title":"Gynecologic and Obstetric Investigation"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1136\/bmj.312.7045.1508","article-title":"Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial","volume":"312","author":"Clifford","year":"1996","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD003511.pub5-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0301-2115(01)00418-3","article-title":"A randomised trial of progesterone prophylaxis after midtrimester amniocentesis","volume":"100","author":"Corrado","year":"2002","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"2","key":"10.1002\/14651858.CD003511.pub5-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0002-9378(88)90127-5","article-title":"Progesterone profiles in luteal phase defect cycles and outcome of progesteron treatment in patients with recurrent spontaneous abortion","volume":"158","author":"Daya","year":"1988","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0029|cit29","first-page":"1461","article-title":"An attempted double-blind controlled trial of progesterone therapy in habitual abortion","volume":"128","author":"Fuchs","year":"1966","journal-title":"Ugeskrift for Laeger"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0030|cit30","first-page":"26","article-title":"Double-blind controlled trial of progesterone substitution in threatened abortion","volume":"8","author":"Gerhard","year":"1987","journal-title":"Biological Research in Pregnancy and Perinatology"},{"issue":"14","key":"10.1002\/14651858.CD003511.pub5-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJM197510022931401","article-title":"Efficacy of 17 alpha-hydroxyprogesterone caproate on the prevention of premature labour","volume":"298","author":"Johnson","year":"1975","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003511.pub5-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/humrep\/der012","article-title":"Does cessation of progesterone supplementation during early pregnancy in patients treated with recFSH\/GnRH antagonist affect ongoing pregnancy rates? A randomized controlled trial","volume":"26","author":"Kyrou","year":"2011","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1471-0528.1965.tb01540.x","article-title":"Double blind controlled trial of 6-methyl-17-acetoxyprogesterone in threatened abortion","volume":"72","author":"Moller","year":"1965","journal-title":"Journal of Obstetrics and Gynaecology of the British Commonwealth"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0034|cit34","unstructured":"Norman JE Double blind randomised placebo controlled study of progesterone for the prevention of preterm birth in twins (STOPPIT) National Research Register. www.nrr.nhs.uk"},{"issue":"2","key":"10.1002\/14651858.CD003511.pub5-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/humrep\/17.2.357","article-title":"Progesterone supplement during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial","volume":"17","author":"Nyboe Anderson","year":"2002","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD003511.pub5-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humrep\/7.suppl_1.1","article-title":"The effect of 17alpha-hydroxyprogesterone caproate\/oestradiol valerate on the development and outcome of early pregnancies following in vitro fertilization and embryo transfer: a prospective and randomized controlled trial","volume":"7","author":"Prietl","year":"1992","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD003511.pub5-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0015-0282(16)48670-X","article-title":"Fetal malformations following progesterone therapy during pregnancy: a preliminary report","volume":"44","author":"Rock","year":"1985","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD003511.pub5-BIB0038|cit38","first-page":"414","article-title":"Clinical observation on effect of Chinese herbal medicine plus human chorionic gonadotropin and progesterone in treating anticardiolipin antibody-positive early recurrent spontaneous abortion","volume":"22","author":"Shu","year":"2002","journal-title":"Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi\/\/Chinese Journal of Integrated Traditional and Western Medicine"},{"issue":"9","key":"10.1002\/14651858.CD003511.pub5-BIB0039|cit39","first-page":"37","article-title":"The use of acetomepegrenol in the therapy of threatened abortion","volume":"66","author":"Sidelnikova","year":"1990","journal-title":"Akusherstvo i Ginekologiia"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0040|cit40","first-page":"507","article-title":"Randomized prospective trial comparing supplementation of the luteal phase and of early pregnancy by natural progesterone given by intramuscular or vaginal administration","volume":"87","author":"Smitz","year":"1992","journal-title":"Revue Francaise de Gynecologie et d Obstetrique"},{"issue":"12","key":"10.1002\/14651858.CD003511.pub5-BIB0041|cit41","first-page":"1227","article-title":"Progesterone treatment of cases of threatened pre-term delivery in women with a low level of plasma progesterone","volume":"13","author":"Sondergaard","year":"1985","journal-title":"Contraception, Fertilite, Sexualite"},{"issue":"8206","key":"10.1002\/14651858.CD003511.pub5-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0140-6736(80)92496-4","article-title":"Progestogens in threatened abortion","volume":"2","author":"Tognoni","year":"1980","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0002-9378(66)90173-6","article-title":"Prolonged gynecologic and endocrine manifestations subsequent to administration of medroxyprogesterone acetate during pregnancy","volume":"95","author":"Turner","year":"1966","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0044|cit44","first-page":"i194, abstract","article-title":"Peri-conceptional progesterone treatment in women with unexplained recurrent miscarriage, a randomized double-blind controlled trial","volume":"30","author":"Ismail","year":"2015","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0045|cit45","unstructured":"Ismail AM Abbas AM Ali MK Amin AF Peri-conceptional progesterone treatment in women with unexplained recurrent miscarriage: a randomized double-blind placebo-controlled trial Journal of Maternal-Fetal & Neonatal Medicine"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0046|cit46","unstructured":"NCT01670929 Pr-conceptional progesterone for unexplained recurrent miscarriage clinicaltrials.gov\/ct2\/show\/record\/NCT01670929"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0047|cit47","unstructured":"ACTRN12611000401954 Does using progesterone reduce the miscarriage rate in high risk pregnancies? Pregnancy Maintenance Trial (PMTrial) www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12611000401954"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0048|cit48","unstructured":"IRCT2013100114853N1 Effect of concomitant administration of vaginal progesterone and vitamin D3 in the treatment of unexplained recurrent abortion in pregnant women en.search.irct.ir\/view\/15255"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0049|cit49","unstructured":"NCT00193674 Oral dydrogesterone treatment during the first trimester of pregnancy in women with recurrent miscarriage: a double-blind, prospectively randomized, placebo-controlled, parallel group trial clinicaltrials.gov\/ct2\/show\/NCT00193674"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0050|cit50","unstructured":"NCT02706470 A randomized, controlled trial of cyclosporin a for women with unexplained recurrent miscarriage clinicaltrials.gov\/ct2\/show\/record\/NCT02706470"},{"issue":"4","key":"10.1002\/14651858.CD003511.pub5-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/14767050500246243","article-title":"Oral dydrogesterone treatment during the first trimester of pregnancy: the prevention of miscarriage study (PROMIS). A double-blind, prospectively randomized, placebo-controlled, parallel group trial","volume":"18","author":"Walch","year":"2005","journal-title":"Journal of Maternal-Fetal & Neonatal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003511.pub5-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008991.pub2","article-title":"Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy","author":"Alfirevic","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0053|cit53","volume-title":"La Psicologia en el Ambito Perinatal","author":"Atkin","year":"1988"},{"issue":"3","key":"10.1002\/14651858.CD003511.pub5-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004353","article-title":"Oestrogen supplementation, mainly diethylstilbestrol, for preventing miscarriages and other adverse pregnancy outcomes","author":"Bamigboye","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0055|cit55","volume-title":"Drugs in Pregnancy and Lactation","author":"Briggs","year":"2011"},{"issue":"4","key":"10.1002\/14651858.CD003511.pub5-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/oxfordjournals.humrep.a137379","article-title":"Incidence of numerical chromosome anomalies in human pregnancy estimation from induced and spontaneous abortion data","volume":"6","author":"Burgoyne","year":"1991","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"d1914","DOI":"10.1136\/bmj.d1914","article-title":"Does first trimester progesterone prophylaxis increase the live birth rate in women with unexplained recurrent miscarriages?","volume":"342","author":"Coomarasamy","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0897.1991.tb00697.x","article-title":"Epidemiology of recurrent spontaneous abortion","volume":"26","author":"Coulam","year":"1991","journal-title":"American Journal of Reproductive Immunology"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0059|cit59","unstructured":"Deeks JJ Higgins JP Altman DG (editors) on behalf of the Cochrane Statistical Methods Group Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"7","key":"10.1002\/14651858.CD003511.pub5-BIB0060|cit60","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004947.pub3","article-title":"Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth","author":"Dodd","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1467-9450.1987.tb00745.x","article-title":"Stillbirth, neonatal death and SIDS: parental reactions","volume":"28","author":"Dyregrove","year":"1987","journal-title":"Scandanavian Journal of Psychology"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1471-0528.1989.tb02385.x","article-title":"A meta-analysis of randomised control trials of progestational agents in pregnancy","volume":"96","author":"Goldstein","year":"1989","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0063|cit63","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0064|cit64","article-title":"Endocrinocolgical and metabolical assessment of early pregnancy","volume-title":"Tumbull's Obstetrics","author":"Grudzinskas","year":"1995"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0066|cit66","unstructured":"Higgins JP Deeks JJ Altman DG (editors) Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0067|cit67","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available fromwww.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0068|cit68","article-title":"Abortion and ectopic pregnancy","volume-title":"Dewhurst's Textbook of Obstetrics and Gynaecology for Postgraduates","author":"Howie","year":"1995"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0002-9378(11)91724-4","article-title":"Luteal phase deficiency. Effect of treatment on pregnancy rates","volume":"167","author":"Karamadian","year":"1992","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD003511.pub5-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1471-0528.1990.tb01740.x","article-title":"Progestogen administration in pregnancy may prevent preterm delivery","volume":"97","author":"Keirse","year":"1990","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"3","key":"10.1002\/14651858.CD003511.pub5-BIB0071|cit71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002857.pub2","article-title":"Uterine muscle relaxant drugs for threatened miscarriage","author":"Lede","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0072|cit72","first-page":"175","article-title":"Spontaneous abortion","volume":"43","author":"McBride","year":"1991","journal-title":"American Family Physician"},{"issue":"1","key":"10.1002\/14651858.CD003511.pub5-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008611.pub2","article-title":"Human chorionic gonadotrophin (hCG) for preventing miscarriage","author":"Morley","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD003511.pub5-BIB0074|cit74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002253.pub3","article-title":"Medical treatment for early fetal death (less than 24 weeks)","author":"Neilson","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003511.pub5-BIB0075|cit75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000112.pub2","article-title":"Immunotherapy for recurrent miscarriage","author":"Porter","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/bmj.299.6698.541","article-title":"Influences of past reproductive performance on risk of spontaneous abortion","volume":"299","author":"Regan","year":"1989","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0077|cit77","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0078|cit78","unstructured":"Royal College of Obstetricians and Gynaecologists The management of recurrent miscarriage www.rcog.org.uk\/guidelines\/recurrent.html (accessed 2001)"},{"issue":"1","key":"10.1002\/14651858.CD003511.pub5-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004073.pub3","article-title":"Vitamin supplementation for preventing miscarriage","author":"Rumbold","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003511.pub5-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.fertnstert.2016.10.031","article-title":"Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials","volume":"107","author":"Saccone","year":"2017","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"Epub 24 March","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"152","author":"Schulz","year":"2010","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0082|cit82","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A (editors) Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Updated October 2013 Available from gdt.gradepro.org\/app\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0083|cit83","article-title":"Fetal wastage","volume-title":"Obstetrics. Normal and Problem Pregnancies","author":"Simpson","year":"1991"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0084|cit84","unstructured":"Sterne JA Egger M Moher D Boutron I (editors) Chapter10: Addressing reporting biases. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"4","key":"10.1002\/14651858.CD003511.pub5-BIB0085|cit85","first-page":"233","article-title":"Management of threatened abortion","volume":"2","author":"Szabo","year":"1996","journal-title":"Early Pregnancy"},{"issue":"5","key":"10.1002\/14651858.CD003511.pub5-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"292","DOI":"10.5694\/j.1326-5377.1991.tb142283.x","article-title":"Early parental responses to sudden infant death, stillbirth or neonatal death","volume":"155","author":"Vance","year":"1991","journal-title":"Medical Journal of Australia"},{"issue":"8","key":"10.1002\/14651858.CD003511.pub5-BIB0087|cit87","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005943.pub5","article-title":"Progestogen for treating threatened miscarriage","author":"Wahabi","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003511.pub5-BIB0088|cit88","volume-title":"Pregnancy Loss: Medical Therapeutics and Practical Considerations","author":"Woods","year":"1987"},{"issue":"2","key":"10.1002\/14651858.CD003511.pub5-BIB0089|cit89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003511.pub2","article-title":"Progestogen for preventing miscarriage","author":"Haas","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD003511.pub5-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003511.pub3","article-title":"Progestogen for preventing miscarriage","author":"Haas","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003511.pub5-BIB0091|cit91","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003511","article-title":"Progestogen for preventing miscarriage","author":"Oates-Whitehead","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003511.pub6","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003511.pub5\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:21:58Z","timestamp":1628544118000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003511.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Pregnancy and Childbirth Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,11,20]]},"references-count":91,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003511.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,20]]}}}